The current study looked at treatment data from 2 randomized trials conducted by the Women’s Health Initiative with long term follow up. The effects of MHT on incidence and mortality from ovarian ...

Researchers say that in the course of developing a new model for ovarian cancer, they've developed additional evidence that serous uterine cancer possibly begins in the fallopian tubes, not the uterus ...

A lab in Denver, Colorado is transforming the way women learn if they have ovarian cancer. Researchers are feeling optimistic about a drug that is commonly used to treat congestive heart failure as an ...

Analysis of data from over 1.2 million US patients with gynecologic cancers between 2004 and 2020 revealed a significant shift towards surgical de-escalation, with increased use of minimally invasive ...

A label expansion for Keytruda in platinum-resistant ovarian cancer would further entrench MSD’s dominance in the PD-1 space.

Eisai Co (($ESALF)) announced an update on their ongoing clinical study. Study Overview: Eisai Co. is conducting a multicenter, open-label Phase ...

Data presented today as an oral presentation at 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics ...

During a trip to France in the 2000s, Carolyn Taylor remembers feeling depressed, unusual for her, especially on vacation. She also noticed she was bleeding between her periods, so she contacted her ...

What Is Metastatic Endometrial Cancer? Metastatic endometrial cancer is when cancer that starts in the lining of the uterus (endometrium) spreads to other parts of the body. Your doctor may call it ...

Uterine cancer symptoms include irregular bleeding and pelvic pain, but early diagnosis through medical evaluation can lead ...

Ibuprofen is a household name – the go-to remedy for everything from headaches to period pain. But recent research suggests ...